BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liaw YF, Chen JJ, Chen TJ. Acute exacerbation in patients with liver cirrhosis: A clinicopathological study. Liver. 1990;10:177-184. [PMID: 1696678 DOI: 10.1111/j.1600-0676.1990.tb00455.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Yuan L, Zeng BM, Liu LL, Ren Y, Yang YQ, Chu J, Li Y, Yang FW, He YH, Lin SD. Risk factors for progression to acute-on-chronic liver failure during severe acute exacerbation of chronic hepatitis B virus infection. World J Gastroenterol 2019;25:2327-37. [PMID: 31148904 DOI: 10.3748/wjg.v25.i19.2327] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
2 Cho JH, Lim JH, Park GY, Kim JS, Kang YJ, Kwon O, Choi JY, Park SH, Kim YL, Kim HK. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection. Transpl Infect Dis. 2014;16:295-303. [PMID: 24628837 DOI: 10.1111/tid.12202] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
3 Peng CY, Chien RN, Liaw YF. Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy. J Hepatol. 2012;57:442-450. [PMID: 22504333 DOI: 10.1016/j.jhep.2012.02.033] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 13.2] [Reference Citation Analysis]
4 Chu CW, Hwang SJ, Luo JC, Lai CR, Tsay SH, Li CP, Wu JC, Chang FY, Lee SD. Clinical, virologic, and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C. J Clin Gastroenterol. 2001;32:240-244. [PMID: 11246354 DOI: 10.1097/00004836-200103000-00014] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 3.3] [Reference Citation Analysis]
5 Dusheiko GM, Roberts JA. Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal. Hepatology 1995;22:1863-73. [DOI: 10.1002/hep.1840220636] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
6 Colombari R, Dhillon AP, Piazzola E, Tomezzoli AA, Angelini GP, Capra F, Tomba A, Scheuer PJ. Chronic hepatitis in multiple virus infection: histopathological evaluation. Histopathology. 1993;22:319-325. [PMID: 8514275 DOI: 10.1111/j.1365-2559.1993.tb00130.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.3] [Reference Citation Analysis]
7 Chang ML, Cheng JS, Chien RN, Liaw YF. Hepatitis Flares Are Associated With Better Outcomes Than No Flare in Patients With Decompensated Cirrhosis and Chronic Hepatitis B Virus Infection. Clin Gastroenterol Hepatol 2020;18:2064-2072.e2. [PMID: 31982607 DOI: 10.1016/j.cgh.2020.01.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Chang ML, Liaw YF. Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management. J Hepatol. 2014;61:1407-1417. [PMID: 25178562 DOI: 10.1016/j.jhep.2014.08.033] [Cited by in Crossref: 147] [Cited by in F6Publishing: 127] [Article Influence: 21.0] [Reference Citation Analysis]
9 Floreani A, Boninsegna S, Lobello S, Caroli D, Fagiuoli S. Fatal hepatic decompensation in a bone marrow transplant recipient with HBV-related cirrhosis following lamivudine withdrawal. Gastroentérologie Clinique et Biologique 2006;30:307-9. [DOI: 10.1016/s0399-8320(06)73171-2] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
10 Calvaruso V, Craxì A. Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible? Liver Int. 2014;34 Suppl 1:85-90. [PMID: 24373083 DOI: 10.1111/liv.12395] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
11 Tsai WL, Sun WC, Cheng JS. Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation. Int J Mol Sci. 2015;16:28126-28145. [PMID: 26703566 DOI: 10.3390/ijms161226087] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
12 Amblàs-Novellas J, Murray SA, Espaulella J, Martori JC, Oller R, Martinez-Muñoz M, Molist N, Blay C, Gómez-Batiste X. Identifying patients with advanced chronic conditions for a progressive palliative care approach: a cross-sectional study of prognostic indicators related to end-of-life trajectories. BMJ Open 2016;6:e012340. [PMID: 27645556 DOI: 10.1136/bmjopen-2016-012340] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 8.2] [Reference Citation Analysis]
13 Abdel-Razik A, Mousa N, Abdel-Aziz M, Elhelaly R, Elzehery R, Zalata K, Elkashef W, Fouda O, Awad M, Hafez M, Eldars W. Elevated serum α-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story. Eur J Gastroenterol Hepatol 2016;28:313-22. [PMID: 26618566 DOI: 10.1097/MEG.0000000000000534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
14 Yang F, Liu Y, Zeng B, Chu J, Hu H, Yang Y, Chen H, Tian C, Li Y, Lin S. Noninvasive assessment of liver fibrosis for predicting acute-on-chronic liver failure in patients with chronic hepatitis B. Hepatol Int 2021;15:593-601. [PMID: 33389677 DOI: 10.1007/s12072-020-10106-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chien RN, Lin CH, Liaw YF. The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B. J Hepatol. 2003;38:322-327. [PMID: 12586298 DOI: 10.1016/s0168-8278(02)00419-1] [Cited by in Crossref: 79] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
16 Tseng PL, Lu SN, Tung HD, Wang JH, Changchien CS, Lee CM. Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis. J Viral Hepat. 2005;12:386-392. [PMID: 15985009 DOI: 10.1111/j.1365-2893.2005.00608.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
17 Zhang Q, Deng YL, Liu C, Huang LH, Shang L, Chen XG, Wang LT, Du JZ, Wang Y, Wang PX, Zhang H, Shen ZY. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation. World J Gastroenterol 2016;22:9571-85. [PMID: 27920478 DOI: 10.3748/wjg.v22.i43.9571] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
18 Yu W, Zhao C, Shen C, Wang Y, Lu H, Fan J. The efficacy and safety of Nucleos(t)ide analogues in patients with spontaneous acute exacerbation of chronic hepatitis B: a systematic review and meta-analysis. PLoS One 2013;8:e65952. [PMID: 23776577 DOI: 10.1371/journal.pone.0065952] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
19 van Bömmel F, Berg T. Treatment of HBV related cirrhosis. Liver Int. 2013;33 Suppl 1:176-181. [PMID: 23286862 DOI: 10.1111/liv.12074] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
20 Chen YC, Chu CM, Yeh CT, Liaw YF. Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study. Hepatol Int. 2007;1:267-273. [PMID: 19669348 DOI: 10.1007/s12072-007-5001-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 6.8] [Reference Citation Analysis]
21 Liaw Y, Chien R, Sheen I, Lin D, Lin H, Chu C. Hepatitis C virus infection in patients with chronic liver diseases in an endemic area for hepatitis B virus infection. Gastroenterol Jpn 1991;26:167-9. [DOI: 10.1007/bf02779291] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Jeng WJ, Sheen IS, Liaw YF. Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B. Clin Gastroenterol Hepatol. 2010;8:541-545. [PMID: 20298811 DOI: 10.1016/j.cgh.2010.02.023] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
23 Luvisa BK, Hassanein TI. Hepatitis B Virus Infection and Liver Decompensation. Clin Liver Dis. 2016;20:681-692. [PMID: 27742007 DOI: 10.1016/j.cld.2016.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
24 Kim JH, Park JW, Koh DW, Lee WJ, Kim CM. Efficacy of lamivudine on hepatitis B viral status and liver function in patients with hepatitis B virus-related hepatocellular carcinoma. Liver Int. 2009;29:203-207. [PMID: 18662281 DOI: 10.1111/j.1478-3231.2008.01828.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
25 Russo FP, Rodríguez-Castro K, Scribano L, Gottardo G, Vanin V, Farinati F. Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease. World J Hepatol 2015;7:1097-104. [PMID: 26052398 DOI: 10.4254/wjh.v7.i8.1097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
26 Kwon H, Moon Y, Jung K, Sang B, Hwang G. Diabetes With or Without Hypertension Does Not Affect Graft Survival and All-cause Mortality After Liver Transplant: A Propensity Score Matching Analysis. Transplantation Proceedings 2018;50:1123-8. [DOI: 10.1016/j.transproceed.2018.01.045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Ferrell L. Liver pathology: cirrhosis, hepatitis, and primary liver tumors. Update and diagnostic problems. Mod Pathol. 2000;13:679-704. [PMID: 10874674 DOI: 10.1038/modpathol.3880119] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 2.5] [Reference Citation Analysis]
28 Lim SG, Wai CT, Rajnakova A, Kajiji T, Guan R. Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B. Gut. 2002;51:597-599. [PMID: 12235087 DOI: 10.1136/gut.51.4.597] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
29 Jeng WJ, Liaw YF. Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis. Semin Liver Dis 2021;41:349-57. [PMID: 34182587 DOI: 10.1055/s-0041-1729973] [Cited by in F6Publishing: 1] [Reference Citation Analysis]